Drugs / COVAXIS®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00304265 | Mar → Oct 2006 | diphtheria, pertussis, poliomyelitis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVAXIS | “COVAXIS® (Tdap: combination diphtheria, tetanus and acellular pertussis) vaccine” NCT00304265 ↗ |
| Modality | Vaccine | “COVAXIS® (Tdap: combination diphtheria, tetanus and acellular pertussis) vaccine” NCT00304265 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00304265 ↗ |